Startup at the PABC nets SBIR grant from National Cancer Institute to continue work on a new GI drug
Dr. Kunwar Shailubhai Biotech entrepreneur and Blumberg Institute professor Kunwar Shailubhai, PhD, the pioneer of therapeutic applications of guanylate cyclase-C (GC-C) signaling and an inventor of the widely prescribed medicine Trulance(R), has been awarded a Phase 1